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ABSTRACT
￿
The carbohydrate requirement for alignment and fusion of embryonic quail muscle
cells has been examined in tissue culture by use of tunicamycin (TM) . The mononucleated,
spindle-shaped proliferating myoblasts were treated with TM at various times before fusion
and differentiation into multinucleated muscle fibers capable of spontaneous contraction.
Tm blocked protein glycosylation and expression of glycoproteins on the cell surface, and
strongly inhibited fusion when added to cultures of differentiating muscle cells before the
fusion "burst," but had no apparent effect on cell alignment. The inhibition of fusion was
partially prevented when TM was administered in the presence of protease inhibitors such as
leupeptin and pepstatin, but the inhibition of glycosylation was not prevented . Both glycosyl-
ation and fusion were completely restored to normal by the removal of the antibiotic from the
medium .
These studies provide strong support for the idea that myoblast fusion is partially mediated
by glycoproteins with asparagine-linked oligosaccharides. However, the requirement for the
carbohydrate portion of the glycoprotein appears to be indirect in that it acts to stabilize the
protein moiety against proteolytic degradation. Our findings do not rule out the possibility
that oligosaccharide units of surface glycolipids have some role in myoblast fusion .
The cell surface is known to be greatly enriched in complex
carbohydrates, primarily in the form of glycoprotein and gly-
colipids. There is considerable evidence to implicate cell surface
carbohydrates in a variety of cellular reactions including sur-
face recognition (20, 22, 23, 37), transport of metabolites across
cell membranes (17, 26), synthesis of sulfated proteoglycans
(33), and insertion and proper orientation of glycoproteins in
the plasma membrane (13, 31, 32). There is also evidence that
carbohydrates protect glycoproteins against proteolytic degra-
dation (1, 3, 19, 24, 27, 34, 43, 44).
Since the discovery of high levels of developmentally regu-
lated lectin activity in extracts of embryonic muscle tissue (for
reviews, see references 2, 14, and 38), the involvement of
surface carbohydrates in muscle fusion has been a matter of
considerable interest. Although several published reports have
presented data to support this assumption (9, 10), the involve-
ment of cell surface carbohydrate and lectin in muscle fusion
has not been established.
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Muscle cell fusion may be conveniently studied in tissue
culture. When explanted into tissue culture, the mononucle-
ated, spindle-shaped, embryonic myoblasts proliferate for 3-4
d before they fuse and differentiate into multinucleated muscle
fibers. 1-2 d laterthese fibers begin to contract spontaneously,
and typical cross-striations can be observed (6, 15). If muscle
fusion is mediated by the interaction between specific cell
surface carbohydrates and cell surface carbohydrate-binding
proteins (lectins), as has been suggested, then inhibition of
glycosylation would be expected to block fusion.
We have used tunicamycin (TM) to investigate the require-
ment of protein glycosylation for fusion of embryonic quail
breast muscle cells in culture. TM inhibits the synthesis of N-
acetylglucosaminyl pyrophosphoryl polyisoprenol (11, 16, 39,
41, 42). Because this intermediate is required for the synthesis
of N-glycoside-linked oligosaccharides, TM treatment results
in synthesis of glycoproteins deficient in asparagine-linked
oligosaccharides (4, 12, 19, 27, 28, 34, 39, 40).
199We present evidence that myoblast fusion is blocked when
protein glycosylation is strongly impaired by TM treatment.
The protease inhibitors leupeptin and pepstatin substantially
prevent the fusion block in TM-treated cultures without re-
storing glycosylation. These findings suggest that (a) a glyco-
protein is required for fusion, but (b) the requirement for the
carbohydrate portion is indirect in that it serves to stabilize the
glycoprotein against proteolytic degradation, as previously re-
ported (3, 19, 27, 43).
MATERIALS AND METHODS
Cell Culture
Myoblasts were isolated by mechanical dissociation from the pectoral muscle
of 10-d-old Japanese quail and maintained in culture according to the modified
procedure of Konigsberg (15) as described by Parent et al. (30). The cells were
cultured in Eagle's Minimal Essential Medium (MEM) containing Earle's salts,
15% horse serum, 10% chick embryo extract, Eagle's nonessential amino acids,
sodium bicarbonate (1 .2 g/liter), 50 U/ml penicillin, 50 fig/ml streptomycin, and
50 Wg/ml Fungizone . The cells were maintained in a humidified 37°C incubator
with an atmosphere of5% C02 and 95% air.
Primary cultures were seeded at a density of4x 106 cells per 100-mm gelatin-
coated Falcon tissue culture dish (Falcon Labware, Div. Becton, Dickinson &
Co., Oxnard, Calif) and incubated for 24 h. Fibroblast-free secondary cultures
were established by mild trypsinization and were seeded at a density of 10" cells
per 60-mm gelatin-coated dish in 3 ml of growth medium. Fresh medium was
added after 48 h and was not changed thereafter during the course of the
experiment. The secondary cultures divided rapidly with a doubling time of -10
h for 3 d. After a brief period ofparallel alignment ofcells ("8 h), a rapid fusion
burst occurred with -70%fusion in 24 h. The percent fusion increased to 85-95%
during the next 2 d. Spontaneous twitching was observed after 5-6 d.
Quantitation of Cell Fusion
Cultures were fixed in 2% glutaraldehyde, stained with Carazzi's hematoxylin
and embedded in a thin layer of polyvinyl alcohol as described by Konigsberg
(15). Improved accuracy of nuclei counting was achieved by treating the fixed
cultures with ribonuclease (50 hg/ml) for l h at 37°C. The dried plastic film
containing the cells was stripped from the plates and mounted onto glass slides.
The number of nuclei in nine random fields (0.55 mm') was counted by phase-
contrast microscopy at a magnification of x 125. The fraction of total nuclei in
multinucleated fibers was calculated.
Other Procedures
Protein synthesis and glycosylation were measured by the incorporation of
["C]leucine (2 fLCi/ml) and [3H]mannose (5 uCi/ml), respectively, into TCA
(10%)-insoluble cellular material, protein was electrophoresed in SDS polyacryl-
amide gels, and fluorograms were prepared. Protein was determined asdescribed
previously (25, 27).
Materials
TM was a gift from Dr. Gakuzo Tamura via the Drug Evaluation Branch of
the National Cancer Institute. The radiochemicals L-[U-"C]leucine (sp act, 2 Ci/
mmol), D-[U-"C]glucosamine (sp act, 238 mCi/mmol), D-[U-"C]galactose (200
MCi/mmol), L-[U-"C]fucose (250 mCi/mmol) and D-[2-sH]mannose (sp act, 2
Ci/mmol) were purchased from New England Nuclear, Boston, Mass. Eagle's
Minimum EssentialMedium, horse serum,and antibioticmixture were purchased
from Grand Island Biological Co., Grand Island, N. Y. Collagen, trypsin, and
soybean trypsin inhibitor were obtained from Worthington Biochemical Corp.,
Freehold, N. J. Cycloheximide, leupeptin, pepstatin, and thindigalactoside were
purchased from Sigma Chemical Company, St. Louis, Mo.
RESULTS
In the present study we have investigated the possible involve-
ment of cell surface carbohydrates in the differentiation of
embryonic muscle cellsin culture. We explored this possibility
by using TM to inhibit the glycosylation of the major class of
surface glycoproteins, and evaluated its effect on the extent
and rate of myoblast fusion to form myotubes.
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Effect of Tunicamycin on Protein Synthesis and
Glycosylation
To examine the effects of TM on protein synthesis and
glycosylation, quail myoblast cultures were incubated for 6 h
in medium with and without TM; radiolabeled precursors were
then added, and incubation continued for an additional 18 h.
The results of a representative experiment are shown in Table
1. The lowest concentration of TM (0.05 tLg/ml) produced
nearly maximal inhibition ofmannose incorporation into total
TCA-insoluble material (87-93%) and into specific glycopro-
teins (not shown) with minimal inhibition of leucine incorpo-
ration (12-16%). Higher concentrations of TM more strongly
inhibited protein synthesis (35-41%) without further inhibiting
glycosylation significantly. Similar results were obtained when
glycosylation was monitored by the incorporation of glucosa-
mine or fucose (not shown). However, galactose incorporation
was less sensitive to inhibition by TM treatment, as expected,
because galactose is also a major component of the carbohy-
drate structure of serine/threonine or hydroxylysine-linked
oligosaccharide.
TM-treatedcells remain viable forup to 72 h when incubated
in the lowest concentration (0.05 Ag/ml) of the drug. The cells
appear healthy by phase-contrast microscopy and retain the
capacity to synthesize protein and exclude trypan blue. In
addition, the effects of TM on glycosylation and protein syn-
thesis are reversible upon removal of the drug from the me-
dium. At the highest concentration (0.2 Itg/ml), or with longer
exposures to the inhibitor, distinct cytotoxic effects are appar-
ent, and the cells become highly vacuolated and come off the
dish.
To study the relationship between the amount of mannose-
labeled macromolecules on the cell surface and myoblast fu-
sion, we labeled cells with [3H]mannose at various stages of
development and estimated the surface fraction by sensitivity
to trypsinization. For these studies, [3H]mannose was added to
the cultures at consecutive 12-h intervals commencing 24 h
after the establishment of the secondary culture. After labeling
for 18 h the medium was withdrawn and the cultures were
TABLE I
Effects of Tunicamycin on Incorporation of Leucine and
Mannose into Total TCA-insolubleFraction of Cultured
EmbryonicMuscle Cells
Cultured muscle cells were incubated with the radioactive precursor for 18 h
at 37°C after a 6-h preincubation with or without TM, as described in Materials
and Methods. Incorporation was determined by precipitation of protein with
10% TCA, solubilization in 0.5 N NaCH, dilution with Aquasol (New England
Nuclear) of aliquots containing equal amounts of protein to a final volume of
20 ml. Radioactivity in these samples was measured by liquid scintillation
spectrometry. The results represent the average of three experiments, and plus
and minus represent the range.
Precursor
Concen-
tration of
tunica-
mycin
Ag/ml
Incorporation
into protein
cpmlAg
Percent
inhibition
L-leucine 0 2,357 ± 169 0
U- 14C 0.05 2,048 ± 142 14 ± 2
0.10 1,806 ± 126 24 ± 3
0.20 1,564 ± 83 38 ± 3
D-Mannose 0 361 ± 47 0
2-31-1 0.05 37 t 11 90 ± 3
0.10 31±10 92±3
0.20 10±3 98±2incubated in phosphate-buffered saline (PBS, pH 7.4) contain-
ing 10 lag/ml cycloheximide with or without 10 lag/ml trypsin.
After 10 min at 37°C, the incubations were terminated by the
addition of soybean trypsin inhibitor to a final concentration
of 15 lag/ml. Both trypsinized and nontrypsinized cultures were
extracted with 10% TCA, and the amount of radioactivity in
macromolecular material was determined.
Approximately 85-90% ofthe incorporated radioactivity was
released by trypsin treatment at all stages of differentiation.
The total amount of radioactivity in both the intracellular and
surface fractions increased by - 10-fold just before the "fusion
burst" and declined slightly after fusion was completed.
The results indicate (a) that protein glycosylation is blocked
by TM, (b) that trypsin-sensitive carbohydrates, presumably
glycoproteins, are present on the surface of myoblast, and (c)
that their synthesis and exposure on the cell surface are devel-
opmentally regulated.
Effect of TM on Myoblast Fusion
The participation of surface glycoproteins in the fusion of
undifferentiated myoblasts to form differentiated myotubes
was examined by determining whether TM blocked muscle cell
fusion. For these studies cells were incubated in culture me-
dium with or without TM. The capacity ofvarious concentra-
tions of TM to inhibit myoblast fusion, when added at various
stages of development, was tested. TM strongly inhibited the
formation of myotubes at the lowest concentration without
significantly impairing protein synthesis or cell growth. Both
the number of nuclei in myotubes and the number of myotubes
are substantially decreased in cellstreated with TM. The effect
is most prominent when TM is added 12-24 h before the onset
ofthe fusion burst.
The lower percentage of fusion in the TM-treated cultures
compared with that of the control could be a consequence of
either the effects of the drug on protein synthesis, resulting in
a lower cell density, or inhibition of glycosylation. To distin-
guish between these two possibilities, the cells were treated
with various concentrations of cycloheximide to reduce protein
synthesis to the level comparable to that of TM treatment. The
results (not shown) indicated that the inhibition of fusion could
not be accounted for by impairment in protein synthesis be-
cause fusion still occurred when protein synthesis was partially
inhibited with cycloheximide.
To evaluate the effect of cell density on fusion, TM was
added to proliferating myoblast cultures -24 h before the onset
of fusion and incubated for 72 h. The TM-treated cells contin-
ued to proliferate and a confluent monolayer was eventually
obtained; however, fusion was almost completely inhibited
(Fig. 1 b-d). It is also apparent (Fig. 1 c and d) that TM
treatment does not inhibit or impair parallel alignment ofcells.
The effects of TM on glycosylation and fusion are simultane-
ously reversed when the drug is removed from the medium; in
fact, >90% of the cells fuse within 36 h (Fig. 1 e) and looked
similar to fused control cultures (Fig. If).
These results suggest that an asparagine-linked, surface gly-
coprotein is required for myoblast fusion, and the inhibition of
fusion by TM is not simply an indirect effect of decreased rate
of growth or lowercell density.
Leupeptin Prevention of the TM Effect on
Fusion
Experiments were performed to determine whether the car-
bohydrate requirement was direct or indirect, because it had
been reported that nonglycosylated proteins are degraded more
rapidly (3, 19, 27, 34-36, 43) and accumulateon the cell surface
to a lesser extent than do the glycosylated protein species (7, 8,
25, 27, 43, 44). Based on these studies, it is plausible that
inhibition of glycosylation also decreased the exposure or
amount of the protein moiety on the cell surface because of
enhanced proteolysis.
This possibility was investigated by supplementing the TM-
treated cultures with leupeptin. Leupeptin is a relatively non-
toxic inhibitor of proteases such as trypsin, papain, plasmin,
and cathepsin B (18, 21). The cultures incubated with TM plus
leupeptin do not show the inhibition of myoblast fusion seen
with TM alone (Fig. 2a). The reduction in other specific
surface glycoproteins by TM, as determined by a-bungarotoxin
(a-BgT) binding to acetylcholine receptors (AChR) (Fig. 2b)
is also partially prevented by leupeptin. Leupeptin has no effect
on the inhibition of glycosylation by TM (Fig. 2c). The effect
of leupeptin on myoblast fusion is potentiated by the simulta-
neous addition of pepstatin. The percent of cells with single
nuclei in cultures treated with TM plus protease inhibitors is
not significantly different from that obtained for control cul-
tures; however, the individual myotubes contain fewer nuclei,
and hence are smaller than in control cultures as shown in Fig.
3.
In the above experiment, TM and the protease inhibitors
were added simultaneously to the proliferating myoblast cul-
tures. Therefore, it is plausible that treatment with the protease
inhibitors spared from degradation the preexisting, glycosyl-
ated protein required for fusion. This possibility was dimin-
ished by pretreatment of cells with TM for 24 h, before the
addition of the protease inhibitors, to allow for depletion of
the intracellular pool(s) and partial turnover of preexisting
surface fraction. It was found that TM pretreatment did not
significantly decrease the percent offusion, which suggests that
the glycosylated fusion protein(s) apparently did not exist in
abundance 24 h before fusion.
These results indicated that the polypeptide portion of a
glycoprotein(s) is sufficient to mediate membrane fusion. This
suggests that the requirement for carbohydrate is indirect, in
that it protects the protein component against cellular prote-
olysis.
DISCUSSION
The biochemical mechanism(s) of muscle fusion is not known.
It has been suggested that this complex process may involve, in
part, a specific association between cell surface oligosaccharide
receptors and specific cell surface carbohydrate-binding pro-
teins(lectins). We have used TM to determine whether surface
glycoproteins with asparagine-linked oligosaccharides are re-
quired for alignment and fusion of embryonic muscle cells in
culture. We have found that treatment of myoblasts with TM
resulted in three marked effects. First, protein glycosylation, as
monitored by the incorporation of radiolabeled mannose into
TCA-insoluble fraction, was almost completely abolished. Sec-
ond, a comparatively large inhibition of myoblast fusion was
observed, as measured by the fraction of total nuclei present in
myotubes. Third, there was a marked decrease in the surface
exposure of AChR as measured by a-BgT binding.
These results suggest that protein glycosylation is required
for muscle fusion. However, the carbohydrate requirement may
be indirect, because it has been reported that nonglycosylated
proteins degrade more rapidly (3, 19, 27, 34-36, 43) and
accumulate on the cell surface to a lesser extent than do the
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￿
Reversal of the effect of TM on myoblast fusion . TM (0.05 jug/ml) was added to cultures of embryonic muscle cells --24
h before the onset of fusion . Shown are phase-contrast photographs of myoblasts at the time of TM addition (a) and after
incubation with the antibiotic for 24 ( b), 48 (c), or 72 h (d) . Reversal of inhibition 36 h after the 72-h pretreatment is shown in e,
and a comparable untreated control is shown in f.
glycosylated protein species (7, 8, 25, 27, 43, 44) . Based on
these studies, it is plausible that inhibition of glycosylation in
muscle cells also decreased the exposure or amount of the
protein moiety in the cell surface because of enhanced prote-
olysis . We investigated this possibility by inhibiting proteolysis
in TM-treated cells by use ofthe protease inhibitors. We found
that the inhibition of fusion by TM in muscle cultures can
largely be prevented with leupeptin and/or pepstatin, even
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though glycosylation is still inhibited. We conclude that the
asparagine-linked carbohydrate moieties on surface glycopro-
teins are not directly required for the fusion of embryonic
muscle cells to form multinucleated myotubes. Rather, the
protein component of glycoproteins with asparagine-linked
oligosaccharides is required for muscle fusion, and we infer
that the carbohydrate stabilizes the protein against proteolytic
degradation.The molecular mechanism of carbohydrate stabilization of
glycoproteins to proteolysis is unknown. One mechanism may
be that the carbohydrate moiety makes the glycoprotein inac-
cessible to the active site ofproteolytic enzymes either through
steric interference or a carbohydrate-induced conformational
change in the protein. It has been reported that some isolated,
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FIGURE 2
￿
Effect of the simultaneous treatment with tunicamycin
and leupeptin on fusion of myoblasts in culture . Muscle cells were
treated with TM (A; 0.05 tLg/ml), leupeptin (O; 50ILM), or both (A)
for 48 h . AChR on surface membranes of intact cells were measured
by the specific binding of '251-aBgt as described by Prives and Olden
(34) . Cultures were incubated with '251-aBgt (10-a M) in DMEM
containing bovine serum albumin (1 mg/ml) for 1 h . Radioactivity
that remained associated with the cells after five washes with 3-ml
volumes of DMEM was counted bygamma spectroscopy . Specificity
was established by the inhibition of ' 251-aBgt labeling in the pres-
ence of the competitive inhibitor decamethonium (10-5 M) . Protein
glycosylation and fusion were quantitated as described in Materials
and Methods.*, Control .
FIGURE 3
￿
Phase-contrast micrographs of control cultures (a), and
cultures treated with TM plus leupeptin (b), or TM alone (c), as
described in the legend to Fig . 2 .
nonglycosylated protein products are inherently more sensitive
to proteases in vitro than the corresponding glycosylated spe-
cies (3, 29). However, that exogenous lectin (concanavalin A)
can decrease the rate of degradation of AChR in control
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203cultures of muscle cells, but not in cultures grown with TM
(34), suggests an alternative mechanism of carbohydrate sta-
bilization of glycoproteins. Endogenous lectins, which are
found in abundance in muscle cells (2) and appear to be
developmentally regulated (14), could serve to protect the
glycoproteins against proteolysis during intracellular process-
ing and transport. Impairment in processing of glycoproteins
could occur because ofan alteration in thecarbohydrate bind-
ing (lectin) or in the carbohydrate moiety itself.
Another line of evidence that carbohydrates do not directly
participate in myoblast fusion is the observation that myoblast
fusion is not blocked by a variety of sugars. In fact, neither
thiodigalactoside nor lactose, both potent inhibitors of muscle
lectin agglutination of rabbit erythrocytes, had any effect on
myoblast fusion (5).
The major conclusion from this work is that fusion of
embryonic muscle cells is not mediated by the surface inter-
action betweencarbohydrate-binding proteins andasparagine-
linked carbohydrate moieties that are both present on the cell
surface. TM apparently inhibits fusion by decreasing theavail-
ability of a surface glycoprotein required for this process.
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